Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed September 8, 2026.
Golden Helix provides genomic infrastructure and clinical variant analysis and interpretation software. Their platforms enable diagnostic laboratories, hospitals, and genome centers to interpret, manage, and scale Next-Generation Sequencing (NGS) workflows across germline, oncology, prenatal, and pharmacogenomics with integrated interpretation, automation, and data management, emphasizing security, scalability, and clinical-grade reliability.
AI did not recommend this brand in the limited public category test.
Optimly has not yet published a supported competitor set for Golden Helix, Inc.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Official website: https://goldenhelix.com/
Last analyzed: September 8, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile